{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:28:26Z","timestamp":1748302106994},"reference-count":3,"publisher":"Massachusetts Medical Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2017,3,23]]},"DOI":"10.1056\/nejmc1701029","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T17:11:56Z","timestamp":1490202716000},"page":"1195-1195","source":"Crossref","is-referenced-by-count":10,"title":["Selumetinib in Plexiform Neurofibromas"],"prefix":"10.1056","volume":"376","member":"150","reference":[{"key":"r001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605943"},{"key":"r002","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.0090"},{"key":"r003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2016.01.012"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc1701029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T17:13:58Z","timestamp":1490202838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc1701029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":3,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3,23]]}},"alternative-id":["10.1056\/NEJMc1701029"],"URL":"https:\/\/doi.org\/10.1056\/nejmc1701029","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}